(Total Views: 94)
Posted On: 12/21/2022 10:21:05 AM
Post# of 27112

$ARWR News Article - Arrowhead Pharmaceuticals to Present Topline Data from the Phase 2 SEQUOIA Study Evaluating Fazirsiran and Describe Design for Planned Phase 3 Study https://marketwirenews.com/news-releases/arro...58847.html


My Twitter: WhyteStocks